Verdict: strong-buy · peers $614.31 (+36.0%) · method: comparables only

⚠ DCF unavailable: same-period, same-currency gross interest expense is unavailable and cannot be assumed zero, so operating cash flow cannot be reconciled to FCFF. Financial evidence and eligible comparables remain available. · Peers rejected by cohort screen: AXP (sector Financials ≠ Health Care), APA (sector Energy ≠ Health Care), BAC (sector Financials ≠ Health Care).